Other OTC Pharmaceuticals - Rwanda

  • Rwanda
  • In Rwanda, the revenue generated in the Other OTC Pharmaceuticals market amounts to US$11.64m in 2024.
  • It is projected to experience an annual growth rate of 1.95% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue with US$7,171.00m in 2024.
  • Taking into account the total population figures, per person revenues of US$0.81 are generated in 2024.
  • Rwanda's Other OTC Pharmaceuticals market is witnessing a growing demand for traditional herbal remedies.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Rwanda has been experiencing steady growth in recent years.

Customer preferences:
Rwandan consumers have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several factors, including increased awareness about self-medication and the convenience of purchasing medications without a prescription. Additionally, the affordability of OTC drugs compared to prescription medications has also contributed to their popularity among consumers.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals market in Rwanda is the increasing demand for cold and flu medications. This can be attributed to the high prevalence of respiratory infections in the country, particularly during the rainy season. Consumers are seeking OTC remedies to alleviate symptoms such as cough, congestion, and fever. As a result, there has been a rise in the availability and sales of cold and flu medications in the market. Another trend in the market is the growing popularity of herbal and natural OTC remedies. Rwandan consumers are increasingly turning to traditional medicine and herbal remedies for their healthcare needs. This trend can be attributed to cultural beliefs and the perception that natural remedies are safer and have fewer side effects compared to conventional pharmaceuticals. As a result, there has been an increase in the availability and sales of herbal and natural OTC products in the market.

Local special circumstances:
Rwanda's healthcare system has undergone significant improvements in recent years, with increased access to healthcare facilities and services. This has led to a greater demand for OTC pharmaceuticals, as consumers have easier access to pharmacies and drugstores. Additionally, the government has implemented policies to promote the availability and affordability of essential medicines, including OTC drugs. These factors have contributed to the growth of the Other OTC Pharmaceuticals market in Rwanda.

Underlying macroeconomic factors:
Rwanda has experienced steady economic growth in recent years, which has had a positive impact on the healthcare sector. As disposable incomes have increased, consumers have more purchasing power to spend on healthcare products, including OTC pharmaceuticals. Additionally, the government has made efforts to improve healthcare infrastructure and services, further driving the demand for OTC medications. In conclusion, the Other OTC Pharmaceuticals market in Rwanda is growing due to customer preferences for self-medication, the increasing demand for cold and flu medications, and the popularity of herbal and natural remedies. Local special circumstances, such as improvements in the healthcare system and government policies, have also contributed to the market's growth. Furthermore, underlying macroeconomic factors, including economic growth and increased disposable incomes, have fueled the demand for OTC pharmaceuticals in Rwanda.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)